launched an innovative tool for detecting heart diseases, marking its first global release since the launch of Bayer Aspirin for heart disease risk assessment in the United States. He further ...

Taking aspirin regularly cuts the risk of developing pancreatic cancer by 40% in people with diabetes and by 20% in the ...

A study suggests that a common household medicine - aspirin - may provide some much-needed relief for those with heat sensitivity.

Per the release, severe COVID-19 was a “coronary artery disease risk equivalent,” increasing the risk for heart attack, ...

Taking aspirin regularly cuts the risk of developing pancreatic cancer by a fifth, according to research.The Planets cancer ...

Recognizing this point should cause us to resist drawing conclusions regarding aspirin use in patients with heart failure - even those with concomitant coronary artery disease - from data ...

Regular use of aspirin may cut the risk of pancreatic cancer in people with diabetes by 40%, a study has found. It may also ...

The drug also cut cardiovascular outcomes – including death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke or hospitalisation for heart failure – by 14%.

Bayer has entered a strategic collaboration with MOMA Therapeutics to advance a small molecule oncology programme, leveraging the latter’s KNOMATIC platform. The partnership aims to target ...

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market. Verquvo has been approved to reduce risk of ...

People who were hospitalized for Covid but who were also taking low-dose aspirin had no increase in the likelihood of a subsequent heart attack or stroke. That means the risk can be mitigated, ...